N-nonyloxypentyl-L-deoxynojirimycin reduces Stenotrophomonas maltophilia virulence in vitro and in Galleria mellonella infection model.

Front Microbiol · 2026 · PMC13260231 · PMID 42293534

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a worrying trendno p-value reported

Introduction Stenotrophomonas maltophilia has emerged as an important opportunistic pathogen on a global scale, with a worrying trend toward multidrug resistance ( Trifonova and Strateva, 2019 ; Brooke, 2021 ).

also in 390 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

&lt;i&gt;N-&lt;/i&gt;nonyloxypentyl-L-deoxynojirimycin reduces &lt;i&gt;Stenotrophomonas maltophilia&lt;/i&gt; virulence &lt;i&gt;in vitro&lt;/i&gt; and in &lt;i&gt;Galleria mellonella&lt;/i&gt; infection model.

The sentences

<i>N-</i>nonyloxypentyl-L-deoxynojirimycin reduces <i>Stenotrophomonas maltophilia</i> virulence <i>in vitro</i> and in <i>Galleria mellonella</i> infection model.